Sage Journals: Discover world-class research

Abstract

Nurse practitioner (NP) and physician assistant (PA) prescribing can increase access to buprenorphine treatment for opioid use disorder. In this cross-sectional study, we used deidentified claims from approximately 90% of U.S. retail pharmacies (2017–2018) to examine the association of state policies with the odds of receiving buprenorphine treatment from an NP/PA versus a physician, overall and stratified by urban/rural status. From 2017 to 2018, the percentage of buprenorphine treatment episodes prescribed by NPs/PAs varied widely across states, from 0.4% in Alabama to 57.2% in Montana. Policies associated with greater odds of buprenorphine treatment from an NP/PA included full scope of practice (SOP) for NPs, full SOP for PAs, Medicaid pay parity for NPs (reimbursement at 100% of the fee-for-service physician rate), and Medicaid expansion. Although most findings with respect to policies were similar in urban and rural settings, the association of Medicaid expansion with NP/PA buprenorphine treatment was driven by rural counties.

Keywords

nurse practitioners physician assistants buprenorphine opioid use disorder behavioral health care Medicaid

Get full access to this article

View all access options for this article.

References

Abraham

A. J.

Lawler

E. C.

Harris

S. J.

Bagwell Adams

Bradford

W. D.

(2021). Spillover of Medicaid expansion to prescribing of opioid use disorder medications in Medicare part D. Psychiatric Services. Advance online publication. https://doi.org/10.1176/appi.ps.202000824

Ahmad

F. B.

Rossen

L. M.

Sutton

(2021). Provisional drug overdose death counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

American Association of Nurse Practitioners. (2021). State practice environment. Retrieved May 7, 2021, from https://www.aanp.org/advocacy/state/state-practice-environment

American Association of Physician Assistants. (2020). The six key elements of a modern PA practice act. https://www.aapa.org/download/29342/

American Association of Physician Assistants. (2021). How Medicaid covers PA services. https://www.aapa.org/advocacy-central/reimbursement/medicaid/624/

Andrilla

C. H. A.

Moore

T. E.

Patterson

D. G.

Larson

E. H.

(2019). Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update. Journal of Rural Health, 35, 108–112. https://doi.org/10.1111/jrh.12307

Andrilla

C. H. A.

Patterson

D. G.

(2021). Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder. The Journal of Rural Health, 38, 87–92. https://doi.org/10.1111/jrh.12569

Auty

S. G.

Stein

M. D.

Walley

A. Y.

Drainoni

M.-L.

(2020). Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply. Journal of Substance Abuse Treatment, 115, Article 108032. https://doi.org/10.1016/j.jsat.2020.108032

Barnes

Maier

C. B.

Altares Sarik

Germack

H. D.

Aiken

L. H.

McHugh

M. D.

(2017). Effects of regulation and payment policies on nurse practitioners’ clinical practices. Medical Care Research and Review, 74(4), 431–451. https://doi.org/10.1177/1077558716649109

10.

Barnes

Richards

M. R.

McHugh

M. D.

Martsolf

(2018). Rural and nonrural primary care physician practices increasingly rely on nurse practitioners. Health Affairs, 37(6), 908–914. https://doi.org/10.1377/hlthaff.2017.1158

11.

Barnett

M. L.

Lee

Frank

R. G.

(2019). In rural areas, buprenorphine waiver adoption since 2017 driven by nurse practitioners and physician assistants. Health Affairs (Project Hope), 38(12), 2048–2056. https://doi.org/10.1377/hlthaff.2019.00859

12.

Bischof

Greenberg

(2021). Post COVID-19 reimbursement parity for nurse practitioners. OJIN: The Online Journal of Issues in Nursing, 26(2), Article 3. https://doi.org/10.3912/OJIN.Vol26No02Man03

13.

Buerhaus

P. I.

DesRoches

C. M.

Dittus

Donelan

(2015). Practice characteristics of primary care nurse practitioners and physicians. Nursing Outlook, 63(2), 144–153. https://doi.org/10.1016/j.outlook.2014.08.008

14.

Cawley

J. F.

Lane

Smith

Bush

(2016). Physician assistants in rural communities. Journal of the American Academy of Physician Assistants, 29(1), 42–45.

15.

Centers for Disease Control and Prevention. (2020). Drug overdose deaths. https://www.cdc.gov/drugoverdose/deaths/index.html

16.

Clemans-Cope

Lynch

Epstein

Kenney

(2017). Medicaid coverage of effective treatment for opioid use disorder.

17.

Comprehensive Addiction and Recovery Act of 2016, S.524, 114th Cong. (2016).

18.

Connery

H. S.

(2015). Medication-assisted treatment of opioid use disorder. Harvard Review of Psychiatry, 23(2), 63–75. https://doi.org/10.1097/hrp.0000000000000075

19.

Davis

M. A.

Anthopolos

Tootoo

Titler

Bynum

J. P. W.

Shipman

S. A.

(2018). Supply of healthcare providers in relation to county socioeconomic and health status. Journal of General Internal Medicine, 33(4), 412–414. https://doi.org/10.1007/s11606-017-4287-4

20.

Dick

A. W.

Pacula

R. L.

Gordon

A. J.

Sorbero

Burns

R. M.

Leslie

Stein

B. D.

(2015). Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002-11. Health Affairs (Project Hope), 34(6), 1028–1034. https://doi.org/10.1377/hlthaff.2014.1205

21.

Germack

H. D.

Harrison

Poghosyan

Martsolf

G. R.

(2022). Practice patterns, work environments, and job outcomes of rural and urban primary care nurse practitioners. Medical Care Research and Review, 79(1), 161–170.

22.

Harkless

Vece

(2018). Systematic review addressing nurse practitioner reimbursement policy: Part one of a four-part series on critical topics identified by the 2015 nurse practitioner research agenda. Journal of the American Association of Nurse Practitioners, 30(12), 673–682. https://doi.org/10.1097/JXX.0000000000000121

23.

Huhn

A. S.

Dunn

K. E.

(2017). Why aren’t physicians prescribing more buprenorphine? Journal of Substance Abuse Treatment, 78, 1–7. https://doi.org/10.1016/j.jsat.2017.04.005

24.

IMPAQ International. (2019). Buprenorphine prescribing by nurse practitioners, physician assistants, and physicians after CARA 2016. https://www.macpac.gov/publication/buprenorphine-prescribing-by-nurse-practitioners-physician-assistants-and-physicians-after-cara-2016/?sfw=pass1619209149

25.

IQVIA: Real World Data and Insights. (n.d.). https://www.iqvia.com/solutions/%0Dreal-world-evidence/real-world-data-and-insights

26.

Jones

C. M.

Campopiano

Baldwin

McCance-Katz

(2015). National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health, 105(8), e55–e63. https://doi.org/10.2105/AJPH.2015.302664

27.

Kaiser Family Foundation. (n.d.). Status of state action on the Medicaid expansion decision. https://www.kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/

28.

McBain

R. K.

Dick

Sorbero

Stein

B. D.

(2020). Growth and distribution of buprenorphine-waivered providers in the United States, 2007–2017. Annals of Internal Medicine, 172(7), 504–506. https://doi.org/10.7326/m19-2403

29.

McGinty

E. E.

Stone

E. M.

Kennedy-Hendricks

Bachhuber

M. A.

Barry

C. L.

(2020). Medication for opioid use disorder: A national survey of primary care physicians. Annals of internal medicine, 173(2), 160–162. https://doi.org/10.7326/M19-3975

30.

Medicaid and CHIP Payment and Access Commission. (2017a). State Medicaid fee-for-service physician payment policies. https://www.macpac.gov/publication/states-medicaid-fee-for-service-physician-payment-policies/?sfw=pass1620560395

31.

Medicaid and CHIP Payment and Access Commission. (2017b). Report to congress on Medicaid and CHIP June 2017: Chapter 2—Medicaid and the opioid epidemic. https://www.macpac.gov/wp-content/uploads/2017/06/Medicaid-and-the-Opioid-Epidemic.pdf

32.

Moore

D. J.

(2019). Nurse practitioners’ pivotal role in ending the opioid epidemic. Journal for Nurse Practitioners, 15(5), 323–327. https://doi.org/10.1016/j.nurpra.2019.01.005

33.

National Center for Health Statistics. (2014). 2013 NCHS urban-rural classification scheme for counties (Vol. 2).

34.

National Judicial Opioid Task Force. (2019). Promising strategies in providing opioid use disorder treatment to rural, frontier, and other underserved communities. https://www.ncsc.org/__data/assets/pdf_file/0019/17614/oud-txt-in-rural-areas-final.pdf

35.

Nguyen

Muench

Andraka-Christou

Simon

Bradford

W. D.

Spetz

(2021). The association between scope of practice regulations and nurse practitioner prescribing of buprenorphine after the 2016 opioid bill. Medical Care Research and Review, 79(2), 290–298. https://doi.org/10.1177/10775587211004311

36.

Orgera

Tolbert

(2019). The opioid epidemic and Medicaid’s role in facilitating access to treatment. https://www.kff.org/medicaid/issue-brief/the-opioid-epidemic-and-medicaids-role-in-facilitating-access-to-treatment/

37.

Patrick

S. W.

Richards

M. R.

Dupont

W. D.

McNeer

Buntin

M. B.

Martin

P. R.

Davis

M. M.

Davis

C. S.

Hartmann

K. E.

Leech

A. A.

Lovell

K. S.

Stein

B. D.

Cooper

W. O.

(2020). Association of pregnancy and insurance status with treatment access for opioid use disorder. JAMA Network Open, 3(8), Article e2013456. https://doi.org/10.1001/jamanetworkopen.2020.13456

38.

Phillips

S. J.

(2016). 28th Annual APRN legislative update. The Nurse Practitioner, 41(1), 21–48.

39.

Rosenblatt

R. A.

Andrilla

C. H. A.

Catlin

Larson

E. H.

(2015). Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Annals of Family Medicine, 13, 23–26. https://doi.org/10.1370/afm.1735

40.

Ruhm

C. J.

(2018). Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999-2015. Addiction, 113(7), 1339–1344. https://doi.org/10.1111/add.14144

41.

Saloner

Levin

Chang

H.-Y.

Jones

Alexander

G. C.

(2018). Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the affordable care act Medicaid expansion. JAMA Network Open, 1(4), Article e181588. https://doi.org/10.1001/jamanetworkopen.2018.1588

42.

Schuler

M. S.

Heins

S. E.

Smart

Griffin

B. A.

Powell

Stuart

E. A.

Pardo

Smucker

Patrick

S. W.

Pacula

R. L.

Stein

B. D.

(2020). The state of the science in opioid policy research. Drug and Alcohol Dependence, 214, Article 108137. https://doi.org/10.1016/j.drugalcdep.2020.108137

43.

Spetz

Chapman

Tierney

Phoenix

Hailer

(2021). Barriers and facilitators of advanced practice registered nurse participation in medication treatment for opioid use disorder: A mixed methods study. Journal of Nursing Regulation, 12(2), 5–22. https://doi.org/10.1016/S2155-8256(21)00052-1

44.

Spetz

Toretsky

Chapman

Phoenix

Tierney

(2019). Nurse practitioner and physician assistant waivers to prescribe buprenorphine and state scope of practice restrictions. JAMA, 321(14), 1407–1408. https://doi.org/10.1001/jama.2019.0834

45.

Stein

B. D.

Jones

C. M.

Smart

Sheng

Sorbero

(2021). Patient, prescriber, and community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18. Drug and Alcohol Dependence, 221, Article 108569. https://doi.org/10.1016/j.drugalcdep.2021.108569

46.

Thomas

C. P.

Doyle

Kreiner

P. W.

Jones

C. M.

Dubenitz

Horan

Stein

B. D.

(2017). Prescribing patterns of buprenorphine waivered physicians. Drug and Alcohol Dependence, 181, 213–218. https://doi.org/10.1016/j.drugalcdep.2017.10.002

47.

U.S. Census Bureau. (2011). Selected housing characteristics, 2007-2011 American Community Survey 5-year estimates. https://www.census.gov/programs-surveys/acs

48.

U.S. Department of Health and Human Services Health Resources and Services Administration. (n.d.). Area health resources files. 2006-2019. https://data.hrsa.gov/topics/health-workforce/ahrf

49.

Wen

Hockenberry

J. M.

Borders

T. F.

Druss

B. G.

(2017). Impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment. Medical Care, 55(4), 336–341. https://doi.org/10.1097/MLR.0000000000000703

50.

Xue

Smith

J. A.

Spetz

(2019). Primary care nurse practitioners and physicians in low-income and rural areas, 2010-2016. JAMA, 321(1), 102–105. https://doi.org/10.1001/jama.2018.17944

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB

0.35 MB

State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants

Abstract

Keywords

Get full access to this article

References

Supplementary Material